Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

Double Blind ◽

Control Phase ◽

Parallel Group ◽

Faculty Opinions recommendation of Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718340215.793493941 ◽

2014 ◽

Author(s):

Kamran Ghoreschi ◽

Sebastian Volc

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.01.897 ◽

2014 ◽

Vol 71 (3) ◽

pp. 484-492 ◽

Cited By ~ 49

Author(s):

D.S. Krupashankar ◽

Sunil Dogra ◽

Mahendra Kura ◽

Abir Saraswat ◽

Leelavathy Budamakuntla ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1067/mjd.2002.127247 ◽

2002 ◽

Vol 47 (6) ◽

pp. 821-833 ◽

Cited By ~ 251

Author(s):

Gerald G. Krueger ◽

Kim A. Papp ◽

Dow B. Stough ◽

Keith H. Loven ◽

Wayne P. Gulliver ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study

British Journal of Dermatology ◽

10.1111/bjd.18029 ◽

2019 ◽

Vol 181 (6) ◽

pp. 1177-1189 ◽

Cited By ~ 5

Author(s):

D. Thaçi ◽

K. Papp ◽

D. Marcoux ◽

L. Weibel ◽

A. Pinter ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Term Efficacy ◽

Paediatric Patients ◽

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

Advances in Therapy ◽

10.1007/s12325-021-01899-0 ◽

2021 ◽

Author(s):

Lin Cai ◽

Linfeng Li ◽

Hao Cheng ◽

Yangfeng Ding ◽

Zhenshu Biao ◽

...

Keyword(s):

Plaque Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Double‐blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis

Journal of Dermatological Treatment ◽

10.1080/09546630310017843 ◽

2004 ◽

Vol 15 (1) ◽

pp. 14-22 ◽

Cited By ~ 21

Author(s):

M Goodfield ◽

S Kownacki ◽

J Berth‐Jones

Keyword(s):

Plaque Psoriasis ◽

Coal Tar ◽

Double Blind ◽

Parallel Group Study ◽

Parallel Group

Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study

British Journal of Dermatology ◽

10.1111/j.1365-2133.1997.tb08752.x ◽

1997 ◽

Vol 136 (1) ◽

pp. 89-93 ◽

Cited By ~ 40

Author(s):

L. MOLIN ◽

T.P. CUTLER ◽

I. HELANDER ◽

B. NYFORS ◽

N. DOWNES ◽

...

Keyword(s):

Multicentre Study ◽

Plaque Psoriasis ◽

Comparative Efficacy ◽

Double Blind ◽

Parallel Group

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Allergology International ◽

10.1016/j.alit.2016.05.014 ◽

2017 ◽

Vol 66 (1) ◽

pp. 97-105 ◽

Cited By ~ 9

Author(s):

Kimihiro Okubo ◽

Minoru Gotoh ◽

Mikiya Asako ◽

Yasuyuki Nomura ◽

Michinori Togawa ◽

...

Keyword(s):

Allergic Rhinitis ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

Epilepsia ◽

10.1111/j.1528-1167.2008.01946.x ◽

2009 ◽

Vol 50 (3) ◽

pp. 454-463 ◽

Cited By ~ 164

Author(s):

Christian Elger ◽

Peter Halász ◽

Joana Maia ◽

Luis Almeida ◽

Patrício Soares-da-Silva ◽

...

Keyword(s):

Phase Iii ◽

Adjunctive Treatment ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis

International Journal of Dermatology ◽

10.1111/ijd.13117 ◽

2015 ◽

Vol 55 (3) ◽

pp. e147-e155 ◽

Cited By ~ 9

Author(s):

Bruce Strober ◽

Yang Zhao ◽

Mary Helen Tran ◽

Ari Gnanasakthy ◽

Judit Nyirady ◽

...

Keyword(s):

Plaque Psoriasis ◽

Study Data ◽

Phase Iii ◽

Psychometric Validation ◽

Phase Iii Study ◽

Symptom Diary